Regional Anesthesia and Pain Medicine最新文献

筛选
英文 中文
Comparison of femoral triangle plus iPACK blocks with femoral triangle block alone for anterior cruciate ligament reconstruction: a randomized controlled clinical trial on postoperative pain and knee function.
IF 5.1 2区 医学
Regional Anesthesia and Pain Medicine Pub Date : 2025-03-07 DOI: 10.1136/rapm-2024-106108
Fabrice Ferré, Lise Boussaguet, Nicolas Vari, Fabien Pillard, Laetitia Bosch, Anne Ferrier, Cyndie Ba, Bernard Tissot, Rémi Menut, Matt Kurrek, François Labaste, Etienne Cavaignac, Vincent Minville
{"title":"Comparison of femoral triangle plus iPACK blocks with femoral triangle block alone for anterior cruciate ligament reconstruction: a randomized controlled clinical trial on postoperative pain and knee function.","authors":"Fabrice Ferré, Lise Boussaguet, Nicolas Vari, Fabien Pillard, Laetitia Bosch, Anne Ferrier, Cyndie Ba, Bernard Tissot, Rémi Menut, Matt Kurrek, François Labaste, Etienne Cavaignac, Vincent Minville","doi":"10.1136/rapm-2024-106108","DOIUrl":"https://doi.org/10.1136/rapm-2024-106108","url":null,"abstract":"<p><strong>Background: </strong>Anterior cruciate ligament reconstruction (ACLR) can cause severe postoperative pain. However, consensus regarding the most effective regional analgesia is lacking. We hypothesized that, compared with femoral triangle block (FTB) and local infiltration analgesia, adding an iPACK block would decrease postoperative morphine consumption.</p><p><strong>Methods: </strong>Patients scheduled for ACLR under general anesthesia were randomly allocated to the FTB (n=45) or the FTB+iPACK group (n=45). The primary outcome was the cumulative oral morphine equivalent (OME) consumption during the first two postoperative days. Secondary outcomes were maximum pain scores, opioid adverse effects, and knee functional scores (Knee Injury and Osteoarthritis Outcome (KOOS), International Knee Documentation Committee (IKDC) and Lysholm) 3, 6, and 9 months after surgery.</p><p><strong>Results: </strong>Compared with FTB, FTB+iPACK resulted in similar OME consumption (median (IQR)=50 (14-103) vs 60 (32-89) mg, respectively; median of the difference (95% CI): 5 (-14, 28) mg, p=0.49). No significant intergroup differences were found in terms of pain scores, opioid-related side effects, or functional knee recovery. Pain and symptoms subscales of KOOS and IKDC at 9 months were higher for patients with an OME consumption <50 mg within the first two postoperative days, but these statistical differences did not reach the minimal clinically important difference.</p><p><strong>Conclusions: </strong>iPACK block has no additional analgesic benefits for primary ACLR in the setting of a multimodal analgesia regimen including FTB and local infiltration analgesia.</p><p><strong>Trial registration number: </strong>NCT05136352.</p>","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":" ","pages":""},"PeriodicalIF":5.1,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143588235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spinal cord stimulation trial-to-implant ratios: relic or requisite?
IF 5.1 2区 医学
Regional Anesthesia and Pain Medicine Pub Date : 2025-03-07 DOI: 10.1136/rapm-2025-106447
Jay Karri, Eellan Sivanesan, Ryan S D'Souza
{"title":"Spinal cord stimulation trial-to-implant ratios: relic or requisite?","authors":"Jay Karri, Eellan Sivanesan, Ryan S D'Souza","doi":"10.1136/rapm-2025-106447","DOIUrl":"https://doi.org/10.1136/rapm-2025-106447","url":null,"abstract":"<p><p>The trial-to-implant ratio for spinal cord stimulation (SCS) has long served as a cornerstone metric for optimizing patient selection and cost containment. Historically, screening trials played a pivotal role in identifying non-responders, thereby minimizing unnecessary permanent implantations. The utility of the trial paradigm is supported by Medicare data from 2009, which reported a trial-to-implant ratio of 42.5%. However, advancements in SCS technology have significantly transformed the neuromodulation landscape and have been associated with higher rates of trial success. By 2018, the Medicare data showed trial-to-implant ratios exceeding 63%, with randomized clinical trials from 2020 to 2021 reporting ratios exceeding 80%-90%. These significant increases in trial-to-implant ratios suggest that only a minority of SCS candidates do not undergo a subsequent permanent device implantation. As such, re-evaluation of the trial-to-implant paradigm, from the perspective of practicing pain physicians in the USA, in light of evolving clinical practices and economic pressures, is warranted. This discourse explores the benefits and limitations of the trial-to-implant ratio, emphasizing its role as a safeguard against overutilization and a tool for standardizing clinical practices but weighed against its shortcomings including a lack of alignment with long-term outcomes, underscore the need for alternative metrics that include per capita trial utilization and explant-to-implant ratios. European responses to similar questions have resulted in utilizing validated symptom screening tools and direct-to-implant pathways in lieu of a screening trial altogether as potential strategies to optimize SCS utilization while maintaining cost-effectiveness. As healthcare systems adapt to advancements in neuromodulation, a balanced perspective on trial-to-implant ratios and complementary metrics is essential to ensure equitable access, sustainable outcomes and evidence-based care for the future of SCS therapy.</p>","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":" ","pages":""},"PeriodicalIF":5.1,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143588238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Axonal sensitivity and block dynamics. 轴突敏感性和阻滞动态
IF 5.1 2区 医学
Regional Anesthesia and Pain Medicine Pub Date : 2025-03-05 DOI: 10.1136/rapm-2024-105950
J A Wildsmith
{"title":"Axonal sensitivity and block dynamics.","authors":"J A Wildsmith","doi":"10.1136/rapm-2024-105950","DOIUrl":"10.1136/rapm-2024-105950","url":null,"abstract":"<p><p>The role of differential nerve block in the development of analgesia after erector spinae plane block has been questioned. While highly myelinated nerves are more sensitive to local anesthetics than unmyelinated ones in vitro, factors influencing drug diffusion, particularly pKa, are more relevant in the clinical setting. Bupivacaine (the drug most used for an 'analgesic' effect) has a relatively high pKa (8.1), and only 15% of it is present in the lipid permeant, unionized form at pH 7.4 so it will penetrate unmyelinated C fibers relatively easily, but the myelin sheaths around other fiber types are a significant barrier to drug diffusion. The greater sensitivity of myelinated axons to local anesthetic action will only be apparent if the drug can reach their membranes in significant concentrations. In the very dynamic situation pertaining to a local anesthetic injection (no matter the site), diffusion factors mean that the concentration of the drug around the axons is likely to be very low and may result in an effect on unmyelinated fibers only.</p>","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":" ","pages":"280-282"},"PeriodicalIF":5.1,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential electrochemical reactions provoked by prolonged electrical stimulation and neuromodulation: in vitro porcine model. 长时间电刺激和神经调节引起的潜在电化学反应:体外猪模型。
IF 5.1 2区 医学
Regional Anesthesia and Pain Medicine Pub Date : 2025-03-05 DOI: 10.1136/rapm-2022-104234
Jonathan Jenkin Tsui, Jeremy Hopkin Tsui
{"title":"Potential electrochemical reactions provoked by prolonged electrical stimulation and neuromodulation: in vitro porcine model.","authors":"Jonathan Jenkin Tsui, Jeremy Hopkin Tsui","doi":"10.1136/rapm-2022-104234","DOIUrl":"10.1136/rapm-2022-104234","url":null,"abstract":"","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":" ","pages":"276-277"},"PeriodicalIF":5.1,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9414283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abdominal field blocks in minimally invasive surgery and the cutaneous sensory block area.
IF 5.1 2区 医学
Regional Anesthesia and Pain Medicine Pub Date : 2025-03-05 DOI: 10.1136/rapm-2025-106559
Renuka M George, Sylvia H Wilson
{"title":"Abdominal field blocks in minimally invasive surgery and the cutaneous sensory block area.","authors":"Renuka M George, Sylvia H Wilson","doi":"10.1136/rapm-2025-106559","DOIUrl":"https://doi.org/10.1136/rapm-2025-106559","url":null,"abstract":"","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":" ","pages":""},"PeriodicalIF":5.1,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143568866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of restorative neurostimulation for chronic mechanical low back pain in an older population with 2-year follow up. 在老年人群中应用恢复性神经刺激治疗慢性机械性腰背痛,并进行两年随访。
IF 5.1 2区 医学
Regional Anesthesia and Pain Medicine Pub Date : 2025-03-05 DOI: 10.1136/rapm-2023-105032
Ardeshir Ardeshiri, Marco Amann, Simon Thomson, Christopher J Gilligan
{"title":"Application of restorative neurostimulation for chronic mechanical low back pain in an older population with 2-year follow up.","authors":"Ardeshir Ardeshiri, Marco Amann, Simon Thomson, Christopher J Gilligan","doi":"10.1136/rapm-2023-105032","DOIUrl":"10.1136/rapm-2023-105032","url":null,"abstract":"<p><strong>Introduction: </strong>Data on the Medicare-aged population show that older patients are major consumers of low back pain (LBP) interventions. An effective approach for patients with mechanical LBP that has been refractory to conservative management is restorative neurostimulation. The efficacy of restorative neurostimulation has been demonstrated in multiple prospective studies, with published follow-up over 4 years, showing a consistent durable effect.</p><p><strong>Methods: </strong>To further examine the effect of restorative neurostimulation in an older demographic, data from three clinical studies were aggregated: ReActiv8-B prospectively followed 204 patients, ReActiv8-C study prospectively followed 87 patients and ReActiv8-PMCF prospectively followed 42 patients.Two hundred and sixty-one patients were identified with complete 2-year follow-up and divided into cohorts of equal size based of age quartiles.At 2 years from device activation, patients in either cohort were classified by change in disability (Oswestry Disability Index (ODI)) or change in pain score(NRS/VAS) and assessed as proportion of patients per group at each time point. Additionally, health-related quality of life (HRQoL) (EQ5D-5L) was longitudinally compared with baseline. Differences in proportions were assessed using χ<sup>2</sup> and continuous variables by repeated measures analysis of variance.</p><p><strong>Results: </strong>The oldest quartile (n=65) had a median age of 60 (56-82) years compared with the entire population (n=261) who had a median age of 49 (22-82) years. The completer analysis on patients with 2 years of continuous data showed improvement of a 50% in pain was achieved by 62% and 65% and a 15-point ODI improvement in 48% and 60% in the oldest quartile and entire population, respectively. HRQoL (EuroQol 5-Dimension) improved from baselines of 0.568 and 0.544 to 0.763 and 0.769 in the oldest quartile and entire population respectively. All age quartiles improved statistically and clinically over baseline.</p><p><strong>Conclusions: </strong>This aggregate analysis of three independent studies provides insight into the performance of restorative neurostimulation in an older population. Patients derived significant and clinically meaningful benefit in disability, pain and HRQoL. When compared with a similarly indicated cohort of younger patients, there were no statistically or clinically significant differences.</p>","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":" ","pages":"231-236"},"PeriodicalIF":5.1,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140068895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibition of the glutamatergic PVT-NAc projections attenuates local anesthetic-induced neurotoxic behaviors. 抑制谷氨酸能 PVT-NAc 投射可减轻局麻药诱发的神经毒性行为。
IF 5.1 2区 医学
Regional Anesthesia and Pain Medicine Pub Date : 2025-03-05 DOI: 10.1136/rapm-2023-104964
Yu Zou, Xin He, Zhiwen Ye, Zhengyiqi Li, Qulian Guo, Wangyuan Zou, Qianyi Peng
{"title":"Inhibition of the glutamatergic PVT-NAc projections attenuates local anesthetic-induced neurotoxic behaviors.","authors":"Yu Zou, Xin He, Zhiwen Ye, Zhengyiqi Li, Qulian Guo, Wangyuan Zou, Qianyi Peng","doi":"10.1136/rapm-2023-104964","DOIUrl":"10.1136/rapm-2023-104964","url":null,"abstract":"<p><strong>Introduction: </strong>Local anesthetic-induced neurotoxicity contributes to perioperative nerve damage; however, the underlying mechanisms remain unclear. Here, we investigated the role of the paraventricular thalamus (PVT)-nucleus accumbens (NAc) projections in neurotoxicity induced by ropivacaine, a local anesthetic agent.</p><p><strong>Methods: </strong>Ropivacaine (58 mg/kg, intraperitoneal administration) was used to construct the local anesthetic systemic toxicity (LAST) mice model. We first identified neural projections from the PVT to the NAc through the expression of a retrograde tracer and virus. The inhibitory viruses (rAAV-EF1α-DIO-hm4D(Gi)-mCherry-WPREs: AAV2/retro and rAAV-CaMKII-CRE-WPRE-hGh: AAV2/9) were injected into the mice model to assess the effects of the specific inhibition of the PVT-NAc pathway on neurological behaviors in the presence of clozapine-N-oxide. The inhibition of the PVT-NAc pathway was evaluated by immunofluorescence staining of c-Fos-positive neurons and Ca<sup>2+</sup> signals in CaMKIIa neurons.</p><p><strong>Results: </strong>We successfully identified a circuit connecting the PVT and NAc in C57BL/6 mice. Ropivacaine administration induced the activation of the PVT-NAc pathway and seizures. Specific inhibition of NAc-projecting CaMKII neurons in the PVT was sufficient to inhibit the neuronal activity in the NAc, which subsequently decreased ropivacaine-induced neurotoxicity.</p><p><strong>Conclusion: </strong>These results reveal the presence of a dedicated PVT-NAc circuit that regulates local anesthetic-induced neurotoxicity and provide a potential mechanistic explanation for the treatment and prevention of LAST.</p>","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":" ","pages":"243-251"},"PeriodicalIF":5.1,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139486284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of lumbar spine movement during unilateral lower extremity flexion. 单侧下肢屈曲时腰椎运动的研究。
IF 5.1 2区 医学
Regional Anesthesia and Pain Medicine Pub Date : 2025-03-05 DOI: 10.1136/rapm-2023-104505
Masashi Fujii, Tsutomu Shirakawa, Yasuyo Kawabata
{"title":"Investigation of lumbar spine movement during unilateral lower extremity flexion.","authors":"Masashi Fujii, Tsutomu Shirakawa, Yasuyo Kawabata","doi":"10.1136/rapm-2023-104505","DOIUrl":"10.1136/rapm-2023-104505","url":null,"abstract":"","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":" ","pages":"278-279"},"PeriodicalIF":5.1,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9400665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In reply: Epidural analgesia after surgery - time to review the gold standard? 回复术后硬膜外镇痛--是时候重新审视黄金标准了?
IF 5.1 2区 医学
Regional Anesthesia and Pain Medicine Pub Date : 2025-03-05 DOI: 10.1136/rapm-2024-105504
Anuj B Patel, Gerard J Kerins, Brian D Sites, Chloe Nadine M Duprat, Matthew Davis
{"title":"In reply: Epidural analgesia after surgery - time to review the gold standard?","authors":"Anuj B Patel, Gerard J Kerins, Brian D Sites, Chloe Nadine M Duprat, Matthew Davis","doi":"10.1136/rapm-2024-105504","DOIUrl":"10.1136/rapm-2024-105504","url":null,"abstract":"","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":" ","pages":"285-286"},"PeriodicalIF":5.1,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141077336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iliopsoas plane block does not improve pain after primary total hip arthroplasty in the presence of multimodal analgesia: a single institution randomized controlled trial. 髂腰肌平面阻滞不能改善初级全髋关节置换术后多模式镇痛的疼痛:一项单机构随机对照试验。
IF 5.1 2区 医学
Regional Anesthesia and Pain Medicine Pub Date : 2025-03-05 DOI: 10.1136/rapm-2023-105092
Ji Yeong Kim, Jong Seok Lee, Ji Young Kim, Eun Jang Yoon, Wootaek Lee, Seungyeon Lee, Do-Hyeong Kim
{"title":"Iliopsoas plane block does not improve pain after primary total hip arthroplasty in the presence of multimodal analgesia: a single institution randomized controlled trial.","authors":"Ji Yeong Kim, Jong Seok Lee, Ji Young Kim, Eun Jang Yoon, Wootaek Lee, Seungyeon Lee, Do-Hyeong Kim","doi":"10.1136/rapm-2023-105092","DOIUrl":"10.1136/rapm-2023-105092","url":null,"abstract":"<p><strong>Background: </strong>The clinical analgesic efficacy of iliopsoas plane block remains a subject of discussion. This study aimed to assess the analgesic efficacy of iliopsoas plane block under general anesthesia using multimodal analgesia.</p><p><strong>Methods: </strong>Fifty-six adult patients who underwent elective primary hip arthroplasty were enrolled. Patients were randomized to receive either a single-shot iliopsoas plane block (10 mL 0.75% ropivacaine with 1:200 000 epinephrine) or a sham block (10 mL normal saline). All patients received general anesthesia, multimodal analgesia (preoperative buprenorphine patch, 5 µg/h), intraoperative intravenous dexamethasone (8 mg) and nefopam (20 mg), and round-the-clock acetaminophen and celecoxib. The primary outcome was the numeric rating scale pain score at rest 6 hour after surgery.</p><p><strong>Results: </strong>Iliopsoas plane block did not have a notable advantage over the sham block in terms of pain relief at rest, as assessed by the numeric rating scale score, 6 hour after total hip arthroplasty (iliopsoas plane block: median, 4.0; IQR, 2.0-5.8; sham: median, 5.5; IQR, 2.3-6.8; median difference, -1.0; 95% CI -2.0 to 0.0; p≥0.999). Linear mixed model analysis showed no differences in pain scores, opioid consumption, quadriceps strength, or quality of recovery between the groups.</p><p><strong>Conclusions: </strong>Iliopsoas plane block did not improve postoperative analgesia following total hip arthroplasty under general anesthesia with a multimodal analgesic regimen. The blockade of sensory femoral branches supplying the anterior hip capsule using iliopsoas plane block may not yield additional benefits concerning patient outcomes in the aforementioned clinical context.</p><p><strong>Trial registration number: </strong>NCT05212038, https://clinicaltrials.gov/ct2/show/NCT05212038.</p>","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":" ","pages":"257-263"},"PeriodicalIF":5.1,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139577128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信